![An oral medication shows benefits treating Type 1 diabetes for at least two years after diagnosis - News | UAB An oral medication shows benefits treating Type 1 diabetes for at least two years after diagnosis - News | UAB](https://www.uab.edu/news/images/2018/Type_1_Diabetes_Stream.jpg)
An oral medication shows benefits treating Type 1 diabetes for at least two years after diagnosis - News | UAB
![Cureus | A Review of Pathogenesis and Risk Factors of Diabetic Retinopathy With Emphasis on Screening Techniques | Article Cureus | A Review of Pathogenesis and Risk Factors of Diabetic Retinopathy With Emphasis on Screening Techniques | Article](https://assets.cureus.com/uploads/figure/file/477350/article_show_04d7f3a05b3111ed92dbcd059312cede-lightbox_9fb7dc704ae011eda00595f807246bbc-updated-3.webp)
Cureus | A Review of Pathogenesis and Risk Factors of Diabetic Retinopathy With Emphasis on Screening Techniques | Article
![Popularity of Ozempic, Mounjaro, similar drugs may be driving shortages for people with diabetes, obesity - ABC News Popularity of Ozempic, Mounjaro, similar drugs may be driving shortages for people with diabetes, obesity - ABC News](https://s.abcnews.com/images/Health/mounjaro-gty-er-230222_1677083998447_hpMain_16x9_1600.jpg)
Popularity of Ozempic, Mounjaro, similar drugs may be driving shortages for people with diabetes, obesity - ABC News
![Axial myopia, a protective factor for diabetic retinopathy-role of vascular endothelial growth factor | Scientific Reports Axial myopia, a protective factor for diabetic retinopathy-role of vascular endothelial growth factor | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-11220-w/MediaObjects/41598_2022_11220_Fig1_HTML.png)